3.0.0 2433 2025-05-27T14:16:45Z 2025-05-27T14:16:45Z Senate S S 2023-07-20 118 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred To 2023-07-20T17:53:02Z 118 3946 HR 2023-06-16 Referred to the Subcommittee on Health. Related bill CRS 118 4063 HR 2023-06-16 Referred to the Subcommittee on Health. Related bill CRS 118 1800 S 2023-06-01 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS 118 5598 HR 2023-09-22 Referred to the Subcommittee on Health. Related bill CRS 118 3070 S 2023-10-18 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS 118 3370 S 2023-11-30 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS 118 7899 HR 2024-04-09 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Related bill CRS 2023-07-20 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2023-07-20 Introduced in Senate IntroReferral 10000 9 Library of Congress C001075 Sen. Cassidy, Bill [R-LA] Bill Cassidy R LA N Health Health 2023-08-30T21:30:22Z

00 2023-07-20 Introduced in Senate 2024-10-15T20:09:00Z <p><strong>SUPPORT for Patients and Communities Reauthorization Act of 2023</strong></p><p>This bill reauthorizes through FY2028 programs and activities relating to mental health and substance use disorder services.</p><p>Reauthorized programs and activities include&nbsp;</p><ul><li>programs that enable access to drugs or devices that temporarily reverse opioid overdoses,</li><li>activities to support the capacity of laboratories to detect synthetic opioids (e.g., fentanyl),</li><li>residential treatment programs for pregnant and postpartum individuals, and</li><li>training and workforce development for providers of mental health and substance use disorder services.</li></ul><p>The bill also modifies certain requirements relating to the regulation of controlled substances and the provision of mental health and substance use disorder services, including by requiring (1) the issuance of federal guidance to support at-home safe disposal systems for drugs, (2) studies to evaluate the efficacy of opioid treatment through buprenorphine and methadone, and (3) evaluations of the use of certain block grants by states to treat individuals with serious mental illnesses.</p>

Display Title 45 2024-07-24T15:20:57Z Short Title(s) as Introduced 101 2024-05-24T13:37:41Z Introduced in Senate IS Official Title as Introduced 6 2023-08-10T01:29:02Z Introduced in Senate IS Introduced in Senate 2023-07-20T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s2433is/xml/BILLS-118s2433is.xml 2023-07-20 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.